ID Cell : evaluation of drug activity PDF Print E-mail

Evaluation of drug activity on human eukaryotic cells : a highly efficient molecule testing service that exploits one of the largest cancer cell line libraries in France

Introduction

ID Cell enables healthcare professionals to evaluate the action of specific molecules on a large panel of cancer-cell lines. One of the key benefits of ID Cell is the vast array of cancer cell lines that are available for research purposes.  Over 30 cell lines are available.  The critical mass of this cell line library can therefore help to ensure that the full potential of a molecule's activity is fully exploited

As well as evaluating drug action on cancer cell lines, ID Cell can also identify any subsequent cellular effects and analyse different tissue types: leukaemic, colon &  lung cancer cell lines etc


leukaemic.jpg

Features/Benefits

  • One of the largest cancer cell-line libraries available in France
    • Ensures that molecules can be matched to specific cancer cell lines increasing the overall accuracy of research results
    • Services are provided by Grenoble UH, Cytology-Histology, Biology & Cell Pathology Department
    • The team is renowned for its work in molecular evaluation. The team's expertise can be incorporated into post-research analysis

Services availablelabo.jpg

  • MTT colorimetric assay enables the measurement of cellular proliferation and therefore cell viability
  • Flow-cytometric approach and fluorescent dyes
  • Cytotoxicity tests for cytotoxic molecules screening
  • Histological analyses and histomorphometry

Applications

  • Morphological analysis and quantification
  • Determination of the apoptosis induction pathway
  • Quantification of the expression of genes
  • Identification and detection of tumorous tissues
  • Determination of drug action on the cell cycle

Commercial Opportunities

Please contact us to find out more about the wide range of molecular screening services that are available from ID Cell.

Contact

Rémy Beroud
Business Developer
+33 (0)4 76 00 78 46
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

 

TECHNOLOGY FOCUS

TESTIMONIALS

"Thanks to the Optical Imaging Platform we have been able to carry out preliminary trials" JS Sun, DNA Therapeutics
Read more...